Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapy

This publication has 9 references indexed in Scilit:

• β-Glucuronyl carbamate based pro-moieties designed for prodrugs in ADEPT
  Tetrahedron Letters, 1995
• Targeting enzymes for cancer therapy: old enzymes in new roles
  British Journal of Cancer, 1994
• A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer
  British Journal of Cancer, 1992
• Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate
  Cancer Immunology, Immunotherapy, 1992
• Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial
  Cell Biochemistry and Biophysics, 1992
• Simple and sensitive quantification of anthracyclines in mouse atrial tissue using high-performance liquid chromatography and fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1991
• Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.
  Journal of Clinical Oncology, 1988
• Protein binding of anthraquinone glycosides, with special reference to adriamycin
  Cancer Chemotherapy and Pharmacology, 1982
• The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters
  Biochemical Journal, 1974